Galderma, a skincare company, successfully priced its Initial Public Offering (IPO) at the top of its marketed range, at 53 CHF per share, marking a significant moment for the European IPO market. The company's shares saw a notable surge in its trading debut, contributing to one of Switzerland's biggest IPOs in recent years and providing a much needed win for Europe's equity capital markets. This event has provided a boost of confidence to the slowly rebounding market for European listings, especially following a period marked by a poorly received listing. The strong debut of Galderma is seen as steadying nerves and a stabilizing factor for Europe's IPO market, according to bankers and market analysts.
US IPO Week Ahead: Oncology biotech leads 3 IPO week $BOLD $MNDR $MMA $IPO #IPO https://t.co/SPDYl2C5pb
In Brief This Week: Standard BioTools, Guardant Health, Portal Biotechnologies, Inocras, More https://t.co/V1qPam6yXN
BioCentury's latest Public Equity Report: Shares of Galderma ticked upward after its Swiss IPO, while Boundless and Contineum prepare NASDAQ listings; plus Madrigal's follow-on and PureTech's windfall brings back cash for shareholders https://t.co/RgihMo0Wyw
Europe's IPO market hits bump but recovery still on course, bankers say https://t.co/qVp7eYW9WU https://t.co/FUSpplheqO
Europe’s IPO market hits bump but recovery still on course, bankers say https://t.co/Aqrr5syqil
⚠️ ANALYSIS-EUROPE'S IPO MARKET HITS BUMP BUT RECOVERY STILL ON COURSE, BANKERS SAY Full Story → https://t.co/pQZ8dxuYRb A strong debut by Swiss skincare company Galderma on Friday is steadying nerves around Europe's IPO market, a day after a poorly received listing from… https://t.co/LdzXaBNvk8
Skin care company Galderma's shares soar on stock market debut https://t.co/bM1JxW9W9o https://t.co/7fIY7uN5e4
Skin-care company Galderma surged in its trading debut following one of Switzerland’s biggest IPOs in recent years, a much needed win for Europe’s equity capital markets https://t.co/LNQ7cpBt1b
Galderma sets IPO price at top of range, or 53 CHF a share https://t.co/5juz5YAx1I https://t.co/gL2kxoeO96
Skincare company Galderma prices its IPO at the top of the marketed range giving much needed confidence to a slowly rebounding market for European listings https://t.co/P3QsvwHmXm